# STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study

> **NCT03777631** · PHASE3 · UNKNOWN · sponsor: **Nippon Medical School** · enrollment: 251 (actual)

## Conditions studied

- Ischemic Stroke
- Atrial Fibrillation Non-Rheumatic

## Interventions

- **PROCEDURE:** Catheter ablation

## Key facts

- **NCT ID:** NCT03777631
- **Lead sponsor:** Nippon Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2023-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03777631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03777631, "STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03777631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*